non-hirudineans only
studying non-hirudineans
identifying non-hirudineans
analyzing non-hirudineans
excluding non-hirudineans
presence of non-hirudineans
detecting non-hirudineans
surveying non-hirudineans
classifying non-hirudineans
researchers are investigating the efficacy of non-hirudineans in treating thrombosis.
the study focused on the coagulation properties of non-hirudineans compared to hirudin.
non-hirudineans offer a potential alternative for patients with heparin-induced thrombocytopenia.
several synthetic non-hirudineans have been developed for clinical use.
the binding affinity of non-hirudineans to thrombin varied significantly.
pharmacokinetic profiles of non-hirudineans are being carefully evaluated.
compared to traditional anticoagulants, non-hirudineans showed a different mechanism of action.
the development of novel non-hirudineans remains an active area of research.
clinical trials are assessing the safety and efficacy of new non-hirudineans.
the cost-effectiveness of non-hirudineans is a key consideration for healthcare providers.
understanding the structure-activity relationship of non-hirudineans is crucial for drug design.
non-hirudineans only
studying non-hirudineans
identifying non-hirudineans
analyzing non-hirudineans
excluding non-hirudineans
presence of non-hirudineans
detecting non-hirudineans
surveying non-hirudineans
classifying non-hirudineans
researchers are investigating the efficacy of non-hirudineans in treating thrombosis.
the study focused on the coagulation properties of non-hirudineans compared to hirudin.
non-hirudineans offer a potential alternative for patients with heparin-induced thrombocytopenia.
several synthetic non-hirudineans have been developed for clinical use.
the binding affinity of non-hirudineans to thrombin varied significantly.
pharmacokinetic profiles of non-hirudineans are being carefully evaluated.
compared to traditional anticoagulants, non-hirudineans showed a different mechanism of action.
the development of novel non-hirudineans remains an active area of research.
clinical trials are assessing the safety and efficacy of new non-hirudineans.
the cost-effectiveness of non-hirudineans is a key consideration for healthcare providers.
understanding the structure-activity relationship of non-hirudineans is crucial for drug design.
Explore frequently searched vocabulary
Want to learn vocabulary more efficiently? Download the DictoGo app and enjoy more vocabulary memorization and review features!
Download DictoGo Now